Biomed Realty Trust Exploring Sale

Biomed Realty Trust (BMR) is trading more than 9% higher in pre-market in reaction to a report from Bloomberg that the company is exploring a sale, and has retained Morgan Stanley as its adviser.

Bloomberg writes that Blackstone Group (BX) is interested in buying the real-estate investment trust, with a market value of approximately $3.9 billion. Sources cited by Bloomberg claim the talks are ongoing, and there is no guarantee a deal will get done.

Shares last traded at $21.00 with a 52-week range of $17.94 to $25.11.

Previous articleAmyris Seals Deal Worth Up to $35 Mln With DARPA
Next articleAMAG Pharmaceuticals’ Abbreviated NDA for Progestin Injection Receives FDA Approval
John Smith
An engineer by degree and blogger by choice. Interested in writing the latest updates happening around the world. Loves to binge watch tv-series and movies.


Please enter your comment!
Please enter your name here